期刊文献+

HLA单倍型相合外周血造血干细胞移植治疗重型地中海贫血 被引量:1

原文传递
导出
摘要 目的 探索单倍型相合外周血造血干细胞移植(PBHSCT)治疗重型地中海贫血的可行性.方法 以氟达拉滨+白舒非+环磷酰胺+ATG+低剂量TBI作为预处理方案,以环孢素A+骁悉+甲氨蝶呤预防GVHD,对5例重型地贫患儿进行单倍型相合PBHSCT.结果中位随访24月,5例患者全部存活,其中4例无病存活.结论 单倍型相合PBHSCT是治疗重型地中海贫血的有效方法.
出处 《中国医师杂志》 CAS 2008年第12期-,共2页 Journal of Chinese Physician
基金 成都军区医学科研计划课题
  • 相关文献

参考文献8

  • 1Hongeng S,Pakakasama S,Chuansumrit A. Outcomes of transplantation with related-and unrelated-donor stem cells in children with severe thalassemia[J].Biology of Blood and Marrow Transplantation,2006,(6):683-687.doi:10.1016/j.bbmt.2006.02.008.
  • 2Sodani P,Gaziev D,Polchi P. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years[J].Blood,2004,(4):1201-1203.doi:10.1182/blood-2003-08-2800.
  • 3韩伟,陆道培,黄晓军,刘开彦,陈欢,许兰平,刘代红,江倩,陈育红,路瑾,王静波,吴彤,董陆佳,任汉云.HLA配型不合造血干细胞移植GIAC方案100例临床分析[J].中华血液学杂志,2004,25(8):453-457. 被引量:68
  • 4Lucarelli G,Gaziev J,Gaziev D. Advances in the allogeneic transplantation for thalassemia[J].Blood Reviews,2008,(2):53-63.doi:10.1016/j.blre.2007.10.001.
  • 5孙爱宁,吴德沛,王荧,仇惠英,金正明,苗瞄,唐晓文,傅铮铮,马骁,韩悦,何广胜,陈苏宁,薛胜利,赵晔.HLA半相合造血干细胞移植治疗恶性血液病的临床观察[J].癌症,2006,25(8):1019-1022. 被引量:9
  • 6Yakushijin K,Matsui T,Okamura A. Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stemcell transplantation[J].Kobe Journal of Medical Sciences,2005.55-65.
  • 7Chalandon Y,Roosnek E,Mermillod B. Prevention of veno-occlusire disease with defibretide after allogeneic stem cell transplantation[J].Biology of Blood and Marrow Transplantation,2004,(5):347-354.doi:10.1016/j.bbmt.2004.01.002.
  • 8王三斌,胡灯明,尹波,刘林,彭利晖.静脉滴注白消安和氟达拉滨预处理方案行异基因造血干细胞移植治疗髓系血液病疗效观察[J].中国实用内科杂志,2007,27(13):1026-1027. 被引量:3

二级参考文献26

  • 1达万明,黄文荣.造血干细胞移植与输血[J].中国实用内科杂志,2004,24(9):521-522. 被引量:4
  • 2戴海滨,王京华,李晓云,夏丽娟,戴晓怡.用低强度Bu/Cy预处理方案进行异基因造血干细胞移植治疗恶性血液病的疗效观察[J].中国实用内科杂志:临床前沿版,2006,26(1):128-129. 被引量:2
  • 3Beatty P G. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants:a Seattle perspective [J]. Bone Marrow Transplant, 1994,14( Suppl 4) : S39-41.
  • 4Ichinohe T, Maruya E, Saji H. Long-term feto-matemal microchimerism: nature's hidden clue for altertive donor hematopoietic cell transplantation? [J]. Int J Hematol, 2002,76(3) :229-237.
  • 5Aversa F, Tetenzi A, Tabilio A, et al. Full Haplotype-Mismatched Hernatopoietic Stem-Cell ransplantation: A Phase Ⅱ Study in Patients With Acute Leukemia at High Risk of Relapse [ J ]. J Clin Oncol, 2005,23 ( 15 ) : 3447-3454.
  • 6Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype [J]. N Engl J Med, 1998,339(17) : 1186-1193.
  • 7Pan L, Delmonte J Jr, Jalonen C K, et al. Pretreatment of donor mice with granulocyte-colong stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease [J].Blood, 1995,86(12) :4422-4429.
  • 8Arpinati M, Loken M, Anasetti C. G-CSF mobilizes type 2-dendritic cell rather than type 1-dendritic cell [J]. Blood,1998,92(Suppl 1 ) : 111a.
  • 9Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med, 1993, 328: 593-602.
  • 10Beatty PG. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants:a Seattle perspective. Bone Marrow Transplant, 1994, 14 Suppl 4: S39-41.

共引文献76

同被引文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部